Ocular Therapeutix grants new SVP Beth Rada options for 85,000 shares, 28,000 RSUs under inducement plan

Reuters2026/08/13 20:19

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Ocular Therapeutix granted inducement equity awards to Beth Rada, its new SVP, Government Affairs and Public Policy.
Package includes a non-statutory stock option for 85,000 shares, priced at $9.24, effective Aug. 10, 2026.
Grant also includes restricted stock units covering 28,000 shares.
Stock option vests over four years, with 25% vesting after one year then monthly; term is 10 years.
RSUs vest over three years in equal annual installments, contingent on continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Ocular Therapeutix grants new SVP Beth Rada options for 85,000 shares, 28,000 RSUs under inducement plan

You may also like

Crypto prices